Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Head and Neck Cancer

Free Subscription Articles published in Int J Cancer Retrieve available abstracts of 108 articles: HTML format

Single Articles

May 2024
1. HUI Z, Wang B, Liu Z, Wei J, et al
   TGFbeta-induced EN1 promotes tumor budding of adenoid cystic carcinoma in patient-derived organoid model.
   Int J Cancer. 2024;154:1814-1827.
   PubMed     Abstract available
   
   
   
2. FANG F, Ritz B, Rao J, Zhu Y, et al
   Association between ambient exposure to PM(2.5) and upper aerodigestive tract cancer in Los Angeles.
   Int J Cancer. 2024;154:1579-1586.
   PubMed     Abstract available
   
   
   April 2024
3. NAKAGAWA T, Santos J, Nasamran CA, Sen P, et al
   Defining the relationship of salivary gland malignancies to novel cell subpopulations in human salivary glands using single nucleus RNA-sequencing.
   Int J Cancer. 2024;154:1492-1503.
   PubMed     Abstract available
   
   
   
4. DI W, Yu J, Zong D, Ge Y, et al
   Effects of ambient temperature, relative humidity and absolute humidity on risk of nasopharyngeal carcinoma in China.
   Int J Cancer. 2024 Apr 10. doi: 10.1002/ijc.34933.
   PubMed     Abstract available
   
   
   
5. LEE JH, Ming Z, Cheung VKY, Pedersen B, et al
   Ex vivo tissue modelling informs drug selection for rare cancers.
   Int J Cancer. 2024;154:1158-1163.
   PubMed     Abstract available
   
   
   March 2024
6. CHARTERS E, Cheng K, Dunn M, Heng C, et al
   Restorabite: Phase II trial of jaw stretching exercises using a novel device for patients with trismus following head and neck cancer.
   Int J Cancer. 2024 Mar 31. doi: 10.1002/ijc.34941.
   PubMed     Abstract available
   
   
   
7. MADRIGAL JM, Troisi R, Surcel HM, Ohman H, et al
   Prediagnostic serum concentrations of per- and polyfluoroalkyl substances and risk of papillary thyroid cancer in the Finnish Maternity Cohort.
   Int J Cancer. 2024;154:979-991.
   PubMed     Abstract available
   
   
   
8. LU Y, Clifford GM, Fairley CK, Grulich AE, et al
   Human papillomavirus and p16(INK4a) in oropharyngeal squamous cell carcinomas: A systematic review and meta-analysis.
   Int J Cancer. 2024;154:830-841.
   PubMed     Abstract available
   
   
   February 2024
9. RINALDI S, Dossus L, Keski-Rahkonen P, Kiss A, et al
   Circulating endogenous sex steroids and risk of differentiated thyroid carcinoma in men and women.
   Int J Cancer. 2024 Feb 15. doi: 10.1002/ijc.34872.
   PubMed     Abstract available
   
   
   
10. SEYYEDSALEHI MS, Boffetta P
    Occupational asbestos exposure and risk of esophageal cancer: A systematic review and meta-analysis.
    Int J Cancer. 2024 Feb 10. doi: 10.1002/ijc.34881.
    PubMed     Abstract available
    
    
    
11. TAYLOR KJ, Amdal CD, Bjordal K, Astrup GL, et al
    Long-term health-related quality of life in head and neck cancer survivors: A large multinational study.
    Int J Cancer. 2024 Feb 5. doi: 10.1002/ijc.34861.
    PubMed     Abstract available
    
    
    January 2024
12. KAIMILA B, Yano Y, Mulima G, Chen Y, et al
    Poor oral health and the risk of esophageal squamous cell carcinoma in Malawi.
    Int J Cancer. 2024 Jan 9. doi: 10.1002/ijc.34829.
    PubMed     Abstract available
    
    
    November 2023
13. STUART CM, Meguid RA, Bronsert MR, Rodriguez Franco S, et al
    The United States experience with diagnosing and treating esophageal cancer during the SARS-CoV-2 pandemic: A retrospective cohort study.
    Int J Cancer. 2023 Nov 28. doi: 10.1002/ijc.34805.
    PubMed     Abstract available
    
    
    
14. 
    Correction to "A risk prediction model for head and neck cancers incorporating lifestyle factors, HPV serology and genetic markers".
    Int J Cancer. 2023 Nov 19. doi: 10.1002/ijc.34789.
    PubMed    
    
    
    
15. RANGEL-POZZO A, Dos Santos FF, Dettori T, Giulietti M, et al
    Three-dimensional nuclear architecture distinguishes thyroid cancer histotypes.
    Int J Cancer. 2023;153:1842-1853.
    PubMed     Abstract available
    
    
    October 2023
16. DOCHI H, Kondo S, Komura S, Moriyama-Kita M, et al
    Peritumoral SPARC expression induced by exosomes from nasopharyngeal carcinoma infected Epstein-Barr virus: A poor prognostic marker.
    Int J Cancer. 2023 Oct 31. doi: 10.1002/ijc.34777.
    PubMed     Abstract available
    
    
    September 2023
17. RAN X, Zeng H, Zheng R, Sun K, et al
    Geographic, sex and socioeconomic disparities in esophageal cancer incidence in China: A population-based study.
    Int J Cancer. 2023 Sep 20. doi: 10.1002/ijc.34730.
    PubMed     Abstract available
    
    
    
18. LEHTINEN M, Butt J, Gray P, Brenner N, et al
    HPV16 E6-antibody associated risk of oropharyngeal cancer increases by calendar-time: A nested case-control study.
    Int J Cancer. 2023;153:1313-1315.
    PubMed    
    
    
    
19. SCOBIOALA S, Parfitt R, Matulat P, Byrne J, et al
    The impact of the temporal sequence of cranial radiotherapy and platin-based chemotherapy on hearing impairment in pediatric and adolescent CNS and head-and-neck cancer patients: A report from the PanCareLIFE consortium.
    Int J Cancer. 2023 Sep 15. doi: 10.1002/ijc.34732.
    PubMed     Abstract available
    
    
    
20. KUSTERS JMA, Diergaarde B, Ness A, Schim van der Loeff MF, et al
    Diagnostic accuracy of HPV16 early antigen serology for HPV-driven oropharyngeal cancer is independent of age and sex.
    Int J Cancer. 2023 Sep 11. doi: 10.1002/ijc.34710.
    PubMed     Abstract available
    
    
    August 2023
21. PIERSIALA K, Hjalmarsson E, da Silva PFN, Lagebro V, et al
    Regulatory B cells producing IL-10 are increased in human tumor draining lymph nodes.
    Int J Cancer. 2023;153:854-866.
    PubMed     Abstract available
    
    
    July 2023
22. GOETZE TO, Hofheinz RD, Gaiser T, Schmalenberg H, et al
    Perioperative FLOT plus ramucirumab for resectable esophagogastric adenocarcinoma: A randomized phase II/III trial of the German AIO and Italian GOIM.
    Int J Cancer. 2023;153:153-163.
    PubMed     Abstract available
    
    
    June 2023
23. SEO S, Keam B, Shin SH, Chae YS, et al
    A phase Ia/Ib study of novel anti-ErbB3 monoclonal antibody, barecetamab (ISU104) in refractory solid cancers and monotherapy or in combination with cetuximab in recurrent or metastatic head and neck cancer.
    Int J Cancer. 2023 Jun 26. doi: 10.1002/ijc.34622.
    PubMed     Abstract available
    
    
    
24. ISHIHARA M, Nishida Y, Kitano S, Kawai A, et al
    A phase 1 trial of NY-ESO-1-specific TCR-engineered T-cell therapy combined with a lymph node-targeting nanoparticulate peptide vaccine for the treatment of advanced soft tissue sarcoma.
    Int J Cancer. 2023;152:2554-2566.
    PubMed     Abstract available
    
    
    May 2023
25. ZHENG XH, Deng CM, Zhou T, Li XZ, et al
    Saliva biopsy: Detecting the difference of EBV DNA methylation in the diagnosis of nasopharyngeal carcinoma.
    Int J Cancer. 2023 May 12. doi: 10.1002/ijc.34561.
    PubMed     Abstract available
    
    
    
26. ZHU H, Yip HC, Cheung MK, Chan HC, et al
    Convergent dysbiosis of upper aerodigestive microbiota between patients with esophageal and oral cavity squamous cell carcinoma.
    Int J Cancer. 2023;152:1903-1915.
    PubMed     Abstract available
    
    
    April 2023
27. DEMIN DE, Murashko MM, Uvarova AN, Stasevich EM, et al
    Adversary of DNA integrity: A long non-coding RNA stimulates driver oncogenic chromosomal rearrangement in human thyroid cells.
    Int J Cancer. 2023;152:1452-1462.
    PubMed     Abstract available
    
    
    March 2023
28. DU Y, Feng R, Chang ET, Yin L, et al
    Body mass index and body shape before treatment and nasopharyngeal carcinoma prognosis: a population-based patient cohort study in southern China.
    Int J Cancer. 2023 Mar 25. doi: 10.1002/ijc.34524.
    PubMed     Abstract available
    
    
    
29. ZHU X, Heng Y, Zhou J, Lin H, et al
    Time-varying association of Second Primary Malignancy and Long-term Survival Outcomes in Patients with Head and Neck Cancer.
    Int J Cancer. 2023 Mar 22. doi: 10.1002/ijc.34520.
    PubMed     Abstract available
    
    
    
30. GHASEMI-KEBRIA F, Semnani S, Fazel A, Etemadi A, et al
    Esophageal and gastric cancer incidence trends in Golestan, Iran: an age-period-cohort analysis 2004-2018.
    Int J Cancer. 2023 Mar 21. doi: 10.1002/ijc.34518.
    PubMed     Abstract available
    
    
    
31. KUIJPER SC, Pape M, Haj Mohammad N, van Voorthuizen T, et al
    SOURCE beyond first-line: A survival prediction model for patients with metastatic esophagogastric adenocarcinoma after failure of first-line palliative systemic therapy.
    Int J Cancer. 2023;152:1202-1209.
    PubMed     Abstract available
    
    
    
32. MOHRING C, Manczak A, Timotheou A, Sadeghlar F, et al
    Perioperative Therapy with Flot4 Significantly Increases Survival in Patients with Gastroesophageal and Gastric Cancer in A Large Real-World Cohort.
    Int J Cancer. 2023 Mar 15. doi: 10.1002/ijc.34511.
    PubMed     Abstract available
    
    
    
33. NGUYEN HT, Tang W, Webster ALH, Whiteaker JR, et al
    Fanconi anemia-isogenic head and neck cancer cell line pairs - a basic and translational science resource.
    Int J Cancer. 2023 Mar 13. doi: 10.1002/ijc.34506.
    PubMed     Abstract available
    
    
    
34. ZHENG XH, Li XZ, Zhou T, Jiang CT, et al
    Quantitative detection of Epstein-Barr virus DNA methylation in the diagnosis of nasopharyngeal carcinoma by blind brush sampling.
    Int J Cancer. 2023 Mar 6. doi: 10.1002/ijc.34491.
    PubMed     Abstract available
    
    
    
35. KUIJPER SC, Pape M, Vissers PAJ, Jeene PM, et al
    Trends in best-case, typical and worst-case survival scenarios of patients with non-metastatic esophagogastric cancer between 2006 and 2020: a population-based study.
    Int J Cancer. 2023 Mar 1. doi: 10.1002/ijc.34488.
    PubMed     Abstract available
    
    
    February 2023
36. PAPE M, Kuijper SC, Vissers PAJ, Ruurda JP, et al
    Conditional relative survival in non-metastatic esophagogastric cancer between 2006 and 2020: a population-based study.
    Int J Cancer. 2023 Feb 25. doi: 10.1002/ijc.34480.
    PubMed     Abstract available
    
    
    
37. LIU T, Bai Y, Lin X, Li W, et al
    First-line nivolumab plus chemotherapy vs chemotherapy in patients with advanced gastric, gastroesophageal junction and esophageal adenocarcinoma: CheckMate 649 Chinese subgroup analysis.
    Int J Cancer. 2023;152:749-760.
    PubMed     Abstract available
    
    
    
38. SIMBA H, Menya D, Mmbaga BT, Dzamalala C, et al
    The contribution of smoking and smokeless tobacco to esophageal squamous cell carcinoma risk in the African esophageal cancer corridor: results from the ESCCAPE multicenter case-control studies.
    Int J Cancer. 2023 Feb 2. doi: 10.1002/ijc.34458.
    PubMed     Abstract available
    
    
    January 2023
39. BUDHATHOKI S, Diergaarde B, Liu G, Olshan A, et al
    A risk prediction model for head and neck cancers incorporating lifestyle factors, HPV serology and genetic markers.
    Int J Cancer. 2023 Jan 24. doi: 10.1002/ijc.34444.
    PubMed     Abstract available
    
    
    
40. SUZUKI H
    HPV hijacks enhancers to activate oncogenes in head and neck squamous cell carcinoma cells.
    Int J Cancer. 2023 Jan 24. doi: 10.1002/ijc.34440.
    PubMed    
    
    
    
41. MIMA M, Okabe A, Hoshii T, Nakagawa T, et al
    Tumorigenic activation around HPV integrated sites in head and neck squamous cell carcinoma.
    Int J Cancer. 2023 Jan 17. doi: 10.1002/ijc.34439.
    PubMed     Abstract available
    
    
    
42. CARVAJAL LJ, Shing JZ, Vanegas JC, Gonzalez E, et al
    TRENDS IN INCIDENCE RATES OF HEAD AND NECK SQUAMOUS CELL CARCINOMAS OVERALL AND BY POTENTIAL RELATEDNESS TO HUMAN PAPILLOMAVIRUS, COSTA RICA 2006-2015.
    Int J Cancer. 2023 Jan 17. doi: 10.1002/ijc.34437.
    PubMed     Abstract available
    
    
    December 2022
43. BOERNER T, Carr RA, Hsu M, Michel A, et al
    Incidence and Management of Esophageal Cancer Recurrence to Regional Lymph Nodes After Curative Esophagectomy.
    Int J Cancer. 2022 Dec 27. doi: 10.1002/ijc.34417.
    PubMed     Abstract available
    
    
    
44. JIN Z, Pei S, Ouyang L, Zhang L, et al
    Thy-Wise: An interpretable machine learning model for the evaluation of thyroid nodules.
    Int J Cancer. 2022;151:2229-2243.
    PubMed     Abstract available
    
    
    November 2022
45. HAO Y, Karaoz U, Yang L, Yachimski PS, et al
    Progressive dysbiosis of human orodigestive microbiota along the sequence of gastroesophageal reflux, Barrett's esophagus and esophageal adenocarcinoma.
    Int J Cancer. 2022;151:1703-1716.
    PubMed     Abstract available
    
    
    
46. YANG H, Wang XK, Wang JB, Zhao FH, et al
    Combined risk factors and risk of upper gastrointestinal cancer mortality in the Linxian general population.
    Int J Cancer. 2022;151:1462-1473.
    PubMed     Abstract available
    
    
    October 2022
47. HERMUS M, van der Wilk BJ, Chang RTH, Collee G, et al
    Patient preferences for active surveillance versus standard surgery after neoadjuvant chemoradiotherapy in esophageal cancer treatment: the NOSANO-study.
    Int J Cancer. 2022 Oct 17. doi: 10.1002/ijc.34327.
    PubMed     Abstract available
    
    
    
48. WANG Q, Xie H, Li Y, Theodoropoulos N, et al
    Racial and ethnic disparities in nasopharyngeal cancer with an emphasis among Asian Americans.
    Int J Cancer. 2022;151:1291-1303.
    PubMed     Abstract available
    
    
    
49. SOROUSH A, Malekzadeh R, Roshandel G, Khoshnia M, et al
    Sex and smoking differences in the association between gastroesophageal reflux and risk of esophageal squamous cell carcinoma in a high-incidence area: Golestan Cohort Study.
    Int J Cancer. 2022 Oct 10. doi: 10.1002/ijc.34313.
    PubMed     Abstract available
    
    
    
50. MA Y, Li W, Chen S, Lin S, et al
    Characteristics and response to next-generation sequencing-guided therapy in locally advanced or metastatic esophageal cancer.
    Int J Cancer. 2022 Oct 10. doi: 10.1002/ijc.34315.
    PubMed     Abstract available
    
    
    September 2022
51. ZHU H, Ma X, Ye T, Wang H, et al
    Esophageal cancer in China: practice and research in the new era.
    Int J Cancer. 2022 Sep 24. doi: 10.1002/ijc.34301.
    PubMed     Abstract available
    
    
    
52. POELL JB, Wils LJ, Brink A, Dietrich R, et al
    Oral cancer prediction by noninvasive genetic screening.
    Int J Cancer. 2022 Sep 7. doi: 10.1002/ijc.34277.
    PubMed     Abstract available
    
    
    August 2022
53. GHOLAP D, Dikshit R, Chaturvedi P, Chaturvedi AK, et al
    Exclusive use of different types of tobacco products, exposure to second hand tobacco smoke and risk of subtypes of head and neck cancer among Indian males.
    Int J Cancer. 2022 Aug 27. doi: 10.1002/ijc.34258.
    PubMed     Abstract available
    
    
    
54. LIU Y, Zheng Z, Li M, Zhang Y, et al
    Comparison of concurrent chemoradiotherapy with radiotherapy alone for locally advanced esophageal squamous cell cancer in elderly patients: A randomized, multicenter, phase II clinical trial.
    Int J Cancer. 2022;151:607-615.
    PubMed     Abstract available
    
    
    
55. TIAN Y, Tang C, Shi G, Wang G, et al
    Novel fluorescent GLUT1 inhibitor for precision detection and fluorescence image-guided surgery in oral squamous cell carcinoma.
    Int J Cancer. 2022;151:450-462.
    PubMed     Abstract available
    
    
    
56. AN L, Zheng R, Zeng H, Zhang S, et al
    The survival of esophageal cancer by subtype in China with comparison to the United States.
    Int J Cancer. 2022 Aug 1. doi: 10.1002/ijc.34232.
    PubMed     Abstract available
    
    
    July 2022
57. NOMBURG J, Bullman S, Nasrollahzadeh D, Collisson EA, et al
    An international report on bacterial communities in esophageal squamous cell carcinoma.
    Int J Cancer. 2022 Jul 15. doi: 10.1002/ijc.34212.
    PubMed     Abstract available
    
    
    June 2022
58. WANG S, Zheng R, Arnold M, Abnet C, et al
    Global and national trends in the age-specific sex ratio of esophageal cancer and gastric cancer by subtype.
    Int J Cancer. 2022 Jun 9. doi: 10.1002/ijc.34158.
    PubMed     Abstract available
    
    
    May 2022
59. IM PK, Yang L, Kartsonaki C, Chen Y, et al
    Alcohol metabolism genes and risks of site-specific cancers in Chinese adults: An 11-year prospective study.
    Int J Cancer. 2022;150:1627-1639.
    PubMed     Abstract available
    
    
    April 2022
60. COLLATUZZO G, Etemadi A, Sotoudeh M, Nikmanesh A, et al
    Meat consumption and risk of esophageal and gastric cancer in the Golestan Cohort Study, Iran.
    Int J Cancer. 2022 Apr 30. doi: 10.1002/ijc.34056.
    PubMed     Abstract available
    
    
    
61. LAAKSONEN MA, MacInnis RJ, Canfell K, Shaw JE, et al
    Thyroid cancers potentially preventable by reducing overweight and obesity in Australia: A pooled cohort study.
    Int J Cancer. 2022;150:1281-1290.
    PubMed     Abstract available
    
    
    
62. LIU H, Li G, Sturgis EM, Shete S, et al
    Genetic variants in CYP2B6 and HSD17B12 associated with the risk of squamous cell carcinoma of the head and neck.
    Int J Cancer. 2022 Apr 11. doi: 10.1002/ijc.34023.
    PubMed     Abstract available
    
    
    
63. GARSET-ZAMANI M, Carlander AF, Jakobsen KK, Friborg J, et al
    Impact of specific high-risk human papillomavirus genotypes on survival in oropharyngeal cancer.
    Int J Cancer. 2022;150:1174-1183.
    PubMed     Abstract available
    
    
    March 2022
64. LONG Z, Wang W, Liu W, Wang F, et al
    Trend of nasopharyngeal carcinoma mortality and years of life lost in China and Its Provinces from 2005 to 2020.
    Int J Cancer. 2022 Mar 14. doi: 10.1002/ijc.33998.
    PubMed     Abstract available
    
    
    
65. RETTIG EM, Faden DL, Sandhu S, Wong K, et al
    Detection of Circulating Tumor Human Papillomavirus DNA Before Diagnosis of HPV-Positive Head and Neck Cancer.
    Int J Cancer. 2022 Mar 9. doi: 10.1002/ijc.33996.
    PubMed     Abstract available
    
    
    February 2022
66. ANTONSSON A, de Souza MMA, Panizza BJ, Whiteman DC, et al
    Sexual debut and association with oral HPV infection, persistence and oropharyngeal cancer - an analysis of two Australian cohorts.
    Int J Cancer. 2022 Feb 28. doi: 10.1002/ijc.33986.
    PubMed     Abstract available
    
    
    
67. LIU J, Li J, Lin W, Shao D, et al
    Neoadjuvant camrelizumab plus chemotherapy for resectable, locally advanced esophageal squamous cell carcinoma (NIC-ESCC2019): a multicenter, phase 2 study.
    Int J Cancer. 2022 Feb 21. doi: 10.1002/ijc.33976.
    PubMed     Abstract available
    
    
    
68. WURSTHORN A, Schwager C, Kurth I, Peitzsch C, et al
    High-Complexity cellular barcoding and clonal tracing reveals stochastic and deterministic parameters of radiation resistance.
    Int J Cancer. 2022;150:663-677.
    PubMed     Abstract available
    
    
    
69. PATEL KK, Chakravarti P, Chaturvedi P, Dikshit R, et al
    The fifth round of the National Family Health Survey of India 2019 to 2021 reported low screening uptake alarming to strengthen the implementation of early detection services of the cervix, breast and oral cancer.
    Int J Cancer. 2022 Feb 6. doi: 10.1002/ijc.33958.
    PubMed    
    
    
    
70. LIU X, Liu P, Chernock RD, Lang Kuhs KA, et al
    Impact of human papillomavirus on the tumor microenvironment in oropharyngeal squamous cell carcinoma.
    Int J Cancer. 2022;150:521-531.
    PubMed     Abstract available
    
    
    
71. DE VEGT F, Gommers JJJ, Groenewoud H, Siersema PD, et al
    Trends and projections in the incidence of oesophageal cancer in the Netherlands: An age-period-cohort analysis from 1989 to 2041.
    Int J Cancer. 2022;150:420-430.
    PubMed     Abstract available
    
    
    
72. GHANTOUS Y, Omar M, Broner EC, Agrawal N, et al
    A robust and interpretable gene signature for predicting the lymph node status of primary T1/T2 oral cavity squamous cell carcinoma.
    Int J Cancer. 2022;150:450-460.
    PubMed     Abstract available
    
    
    January 2022
73. VAN DER WATT PJ, Okpara MO, Wishart A, Parker MI, et al
    Nuclear transport proteins are secreted by cancer cells and identified as potential novel cancer biomarkers.
    Int J Cancer. 2022;150:347-361.
    PubMed     Abstract available
    
    
    
74. GAO P, Cai N, Yang X, Yuan Z, et al
    Association of Helicobacter pylori and gastric atrophy with adenocarcinoma of the esophagogastric junction in Taixing, China.
    Int J Cancer. 2022;150:243-252.
    PubMed     Abstract available
    
    
    
75. KRENS SD, van Boxtel W, Uijen MJM, Jansman FGA, et al
    Exposure-toxicity relationship of cabozantinib in patients with renal cell cancer and salivary gland cancer.
    Int J Cancer. 2022;150:308-316.
    PubMed     Abstract available
    
    
    December 2021
76. DENEUVE S, Perol O, Dantony E, Guizard AV, et al
    Diverging incidence trends of oral tongue cancer compared to other head and neck cancers in young adults in France.
    Int J Cancer. 2021 Dec 10. doi: 10.1002/ijc.33896.
    PubMed     Abstract available
    
    
    November 2021
77. LASSEN P, Huang SH, Su J, Waldron J, et al
    Treatment outcomes and survival following definitive (chemo) radiotherapy in HPV-positive oropharynx cancer: Large-scale comparison of DAHANCA vs PMH cohorts.
    Int J Cancer. 2021 Nov 18. doi: 10.1002/ijc.33876.
    PubMed     Abstract available
    
    
    October 2021
78. TAWK B, Wirkner U, Schwager C, Rein K, et al
    Tumor DNA-Methylome derived Epigenetic Fingerprint Identifies HPV-negative Head and Neck Patients at Risk for Locoregional Recurrence after Postoperative Radiochemotherapy.
    Int J Cancer. 2021 Oct 14. doi: 10.1002/ijc.33842.
    PubMed     Abstract available
    
    
    September 2021
79. DE LA COUR CD, von Buchwald C, Dehlendorff C, Garset-Zamani M, et al
    Low-dose aspirin use and mortality risk in patients with head and neck cancer - a nationwide cohort study of 10,770 patients.
    Int J Cancer. 2021 Sep 18. doi: 10.1002/ijc.33814.
    PubMed     Abstract available
    
    
    
80. CABASAG CJ, Arnold M, Pineros M, Morgan E, et al
    Population-based cancer staging for oesophageal, gastric, and pancreatic cancer 2012-2014: International Cancer Benchmarking Partnership SurvMark-2.
    Int J Cancer. 2021;149:1239-1246.
    PubMed     Abstract available
    
    
    
81. TANAKA H, Suzuki M, Takemoto N, Fukusumi T, et al
    Performance of Oral HPV DNA, Oral HPV mRNA, and Circulating Tumor HPV DNA in the Detection of HPV-Related Oropharyngeal Cancer and Cancer of Unknown Primary.
    Int J Cancer. 2021 Sep 6. doi: 10.1002/ijc.33798.
    PubMed     Abstract available
    
    
    
82. NABHAN F, Dedhia PH, Ringel MD
    Thyroid cancer, recent advances in diagnosis and therapy.
    Int J Cancer. 2021;149:984-992.
    PubMed     Abstract available
    
    
    July 2021
83. NAUTA IH, Heideman DAM, Brink A, van der Steen B, et al
    The unveiled reality of human papillomavirus as risk factor for oral cavity squamous cell carcinoma.
    Int J Cancer. 2021;149:420-430.
    PubMed     Abstract available
    
    
    June 2021
84. BUDUKH A, Dikshit R, Chaturvedi P
    Outcome of the randomized control screening trials on Oral, Cervix and Breast Cancer from India and way forward in COVID-19 pandemic situation.
    Int J Cancer. 2021 Jun 21. doi: 10.1002/ijc.33712.
    PubMed    
    
    
    
85. TRUONG T, Lesueur F, Sugier PE, Guibon J, et al
    Multiethnic genome-wide association study of differentiated thyroid cancer in the EPITHYR consortium.
    Int J Cancer. 2021;148:2935-2946.
    PubMed     Abstract available
    
    
    May 2021
86. HOFHEINZ RD, Hegewisch-Becker S, Kunzmann V, Thuss-Patience P, et al
    Trastuzumab in combination with 5-fluorouracil, leucovorin, oxaliplatin and docetaxel (FLOT) as perioperative treatment for patients with HER2-positive locally advanced esophagogastric adenocarcinoma: A phase II trial of the AIO Gastric Cancer Study G
    Int J Cancer. 2021 May 21. doi: 10.1002/ijc.33696.
    PubMed     Abstract available
    
    
    
87. NARH CT, Dzamalala CP, Mmbaga BT, Menya D, et al
    Geophagia and risk of squamous cell esophageal cancer in the African esophageal cancer corridor - Findings from the ESCCAPE multi-country case-control studies.
    Int J Cancer. 2021 May 18. doi: 10.1002/ijc.33688.
    PubMed     Abstract available
    
    
    April 2021
88. BUSSMANN L, Hoffer K, von Bargen CM, Droste C, et al
    Analyzing tyrosine kinase activity in head and neck cancer by functional kinomics: Identification of hyperactivated Src-family kinases as prognostic markers and potential targets.
    Int J Cancer. 2021 Apr 22. doi: 10.1002/ijc.33606.
    PubMed     Abstract available
    
    
    
89. SHI Z, Wei J, Na R, Resurreccion WK, et al
    Cystic fibrosis F508del carriers and cancer risk: Results from the UK Biobank.
    Int J Cancer. 2021;148:1658-1664.
    PubMed     Abstract available
    
    
    
90. LING Z, Cheng B, Tao X
    Epithelial-to-mesenchymal transition in oral squamous cell carcinoma: Challenges and opportunities.
    Int J Cancer. 2021;148:1548-1561.
    PubMed     Abstract available
    
    
    March 2021
91. MIDDLETON DRS, Mmbaga BT, O'Donovan M, Abedi-Ardekani B, et al
    Minimally invasive esophageal sponge cytology sampling is feasible in a Tanzanian community setting.
    Int J Cancer. 2021;148:1208-1218.
    PubMed     Abstract available
    
    
    
92. IMAMURA Y, Toihata T, Haraguchi I, Ogata Y, et al
    Immunogenic characteristics of microsatellite instability-low esophagogastric junction adenocarcinoma based on clinicopathological, molecular, immunological and survival analyses.
    Int J Cancer. 2021;148:1260-1275.
    PubMed     Abstract available
    
    
    
93. LIU Y, Lai F, Long J, Peng S, et al
    Screening and the epidemic of thyroid cancer in China: An analysis of national representative inpatient and commercial insurance databases.
    Int J Cancer. 2021;148:1106-1114.
    PubMed     Abstract available
    
    
    February 2021
94. PARAD MT, Fararouei M, Mirahmadizadeh AR, Afrashteh S, et al
    Thyroid cancer and its associated factors: a population based case-control study.
    Int J Cancer. 2021 Feb 26. doi: 10.1002/ijc.33537.
    PubMed     Abstract available
    
    
    
95. XIE SH, Ness-Jensen E, Langseth H, Gislefoss RE, et al
    Prediagnostic circulating levels of sex hormones and survival in esophageal adenocarcinoma.
    Int J Cancer. 2021;148:905-913.
    PubMed     Abstract available
    
    
    January 2021
96. TAKADA K, Aizawa Y, Sano D, Okuda R, et al
    Establishment of PDX-derived salivary adenoid cystic carcinoma cell lines using organoid culture method.
    Int J Cancer. 2021;148:193-202.
    PubMed     Abstract available
    
    
    December 2020
97. CHOI J, Jia G, Wen W, Long J, et al
    Evaluating polygenic risk scores in assessing risk of nine solid and hematologic cancers in European descendants.
    Int J Cancer. 2020;147:3416-3423.
    PubMed     Abstract available
    
    
    
98. ANTONSSON A, de Souza M, Wood ZC, Carroll A, et al
    Natural history of oral HPV infection - longitudinal analyses in prospective cohorts from Australia.
    Int J Cancer. 2020 Dec 15. doi: 10.1002/ijc.33442.
    PubMed     Abstract available
    
    
    November 2020
99. SONG L, Zhang S, Yu S, Ma F, et al
    Cellular heterogeneity landscape in laryngeal squamous cell carcinoma.
    Int J Cancer. 2020;147:2879-2890.
    PubMed     Abstract available
    
    
    
100. CAPPAGLI V, Caldarella A, Manneschi G, Piaggi P, et al
     Nonthyroidal second primary malignancies in differentiated thyroid cancer patients: Is the incidence increased comparing to the general population and could it be a radioiodine therapy consequence?
     Int J Cancer. 2020;147:2838-2846.
     PubMed     Abstract available
     
     
     
101. GARCIA RODRIGUEZ LA, Soriano-Gabarro M, Vora P, Cea Soriano L, et al
     Low-dose aspirin and risk of gastric and oesophageal cancer: A population-based study in the United Kingdom using The Health Improvement Network.
     Int J Cancer. 2020;147:2394-2404.
     PubMed     Abstract available
     
     
     
102. JUWEID ME, Tulchinsky M, Mismar A, Momani M, et al
     Contemporary considerations in adjuvant radioiodine treatment of adults with differentiated thyroid cancer.
     Int J Cancer. 2020;147:2345-2354.
     PubMed     Abstract available
     
     
     October 2020
103. BASILI T, Dopeso H, Kim SH, Ferrando L, et al
     Oncogenic properties and signaling basis of the PAX8-GLIS3 fusion gene.
     Int J Cancer. 2020;147:2253-2264.
     PubMed     Abstract available
     
     
     
104. YUAN S, Kar S, Vithayathil M, Carter P, et al
     Causal associations of thyroid function and dysfunction with overall, breast and thyroid cancer: A two-sample Mendelian randomization study.
     Int J Cancer. 2020;147:1895-1903.
     PubMed     Abstract available
     
     
     September 2020
105. SIRRI E, Kieschke J, Vohmann C, Katalinic A, et al
     Survival of malignant mesothelioma and other rare thoracic cancers in Germany and the United States: A population-based study.
     Int J Cancer. 2020;147:1548-1558.
     PubMed     Abstract available
     
     
     August 2020
106. BOSETTI C, Carioli G, Santucci C, Bertuccio P, et al
     Global trends in oral and pharyngeal cancer incidence and mortality.
     Int J Cancer. 2020;147:1040-1049.
     PubMed     Abstract available
     
     
     May 2020
107. MESSERSCHMIDT C, Obermayer B, Klinghammer K, Ochsenreither S, et al
     Distinct immune evasion in APOBEC-enriched, HPV-negative HNSCC.
     Int J Cancer. 2020 May 29. doi: 10.1002/ijc.33123.
     PubMed     Abstract available
     
     
     November 2019
108. VEYER D, Wack M, Mandavit M, Garrigou S, et al
     HPV circulating tumoral DNA quantification by droplet-based digital PCR: a promising predictive and prognostic biomarker for HPV-associated oropharyngeal cancers.
     Int J Cancer. 2019 Nov 22. doi: 10.1002/ijc.32804.
     PubMed    
     
     

Thank you for your interest in scientific medicine.

AMEDEO Head and Neck Cancer is free of charge.